FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA.

被引：0
|
作者：
Pergola, P. E. [1 ]
Fishbane, S. [2 ]
Neylan, J. F. [3 ]
Uhlig, K. [3 ]
Chertow, G. M. [4 ]
机构：
[1] Renal Associates PA, San Antonio, TX USA
[2] Hofstra Northwell Hlth, Great Neck, NY USA
[3] Keryx Biopharmaceut, Boston, MA USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2017年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
238
引用
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [1] Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
    Ito, Kyoko
    Akizawa, Tadao
    Arita, Kojo
    Mitobe, Yuko
    Komatsu, Norio
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (07) : 636 - 646
  • [2] Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia
    Pergola, Pablo E.
    Fishbane, Steven
    LeWinter, Robin D.
    Neylan, John F.
    Uhlig, Katrin
    Block, Geoffrey A.
    Chertow, Glenn M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) : E154 - E156
  • [3] Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency
    Akira Iguchi
    Suguru Yamamoto
    Mihoko Yamazaki
    Kazuyuki Tasaki
    Yasushi Suzuki
    Junichiro James Kazama
    Ichiei Narita
    [J]. Clinical and Experimental Nephrology, 2018, 22 : 789 - 796
  • [4] Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency
    Iguchi, Akira
    Yamamoto, Suguru
    Yamazaki, Mihoko
    Tasaki, Kazuyuki
    Suzuki, Yasushi
    Kazama, Junichiro James
    Narita, Ichiei
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (04) : 789 - 796
  • [5] Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease
    Bunn, H. Franklin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16):
  • [6] Ferric Derisomaltose Evaluation in Patients with Non-Dialysis-Dependent Chronic Kidney Disease or Peritoneal Dialysis
    England, Emma
    Sheffield, Maneka
    Poyah, Penelope
    Clark, David
    Wilson, Jo-Anne
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2023, 76 (02): : 94 - 101
  • [7] Iron and Clinical Outcomes in Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients
    Kovesdy, Csaba P.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 109 - 116
  • [8] HEMOGLOBIN VARIABILITY AND ADVERSE CLINICAL EVENTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND ANEMIA IN CONTINUOUS
    Takahiro, Kuragano
    Okami, Suguru
    Tanaka, Sachiko
    Uenaka, Hidetoshi
    Kimura, Takeshi
    Ishida, Yosuke
    James, Glen
    Hayasaki, Takanori
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I36 - I38
  • [9] Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease
    Pergola, Pablo E.
    Belo, Diogo
    Crawford, Paul
    Moustafa, Moustafa
    Luo, Wenli
    Goldfarb-Rumyantzev, Alexander
    Farag, Youssef M. K.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (07) : 572 - 581
  • [10] Initiation of Darbepoetin for Management of Anemia in Non-dialysis-dependent Patients with Chronic Kidney Disease
    Al Raisi, Fatma
    Al Salmi, Issa
    Kamble, Pramod
    Al Shehri, Muna
    Shaheen, Faissal A. M.
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (06) : 1182 - 1187
12345